Antares Pharma, Inc. (ATRS)

R&D Expenses

$16.87M

TTM · Period ending: · USD

ATRS logo

ATRS R&D Expenses

Latest reported$16.87M
ATRS TTM R&D Expenses ($1.98M → $16.87M)
High-resolution chart · PNG

ATRS r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
16,870,000
14,502,000
12,928,000
11,410,000
9,780,000
10,121,000
10,683,000
11,141,000
11,218,000
10,624,000
9,491,000
10,239,000
11,395,000
12,328,000
14,192,911
13,871,356
13,380,719
13,147,000
15,107,426
17,776,531
18,565,188
21,126,936
21,197,063
20,380,900
21,001,612
19,731,564
19,823,812
19,108,155
18,482,371
18,638,016
15,893,719
15,927,017
16,567,646
15,263,371
17,934,086
17,374,533
15,273,741
14,921,552
10,834,870
8,363,605
7,827,151
6,699,325
7,266,054
8,169,556
8,466,013
8,802,502
8,606,822
8,279,031
7,781,552
7,902,486
7,912,735
8,061,081
8,106,986
7,866,499
7,275,663
6,774,525
6,504,968
5,362,291
5,122,900
4,303,268
3,741,005
3,778,469
3,090,672
3,180,353
3,304,424
3,409,486
4,370,942
4,328,061
3,848,586
3,546,438
3,572,901
3,359,814
3,443,164
3,493,966
3,333,936
3,511,628
3,637,980
3,654,333
3,863,923
3,705,915
3,716,051
3,526,632
2,408,934
2,025,863
1,490,875
1,223,034
1,383,310
1,680,487
1,891,647
2,317,779
3,416,856
3,516,856
3,616,856
3,516,856
2,573,814
2,473,814
2,573,814
2,573,814
2,684,806
2,684,806
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.